Mary Beth Kreissler

Mary Beth Kreissler is currently the Chief Financial Officer at Candesant Biomedical, starting in September 2022. Prior to this role, they served as a CFO Consultant at Life Sciences & MedTech Advisor for 14 years from 2008 to 2022. During their time as a consultant, Mary Beth worked on various projects including strategic and financial planning, debt and equity financing, operating plans and forecasts, exit planning and execution, valuation analyses, and international expansion. Some of their notable engagements included Candesant Biomedical and Revelle Aesthetics. Before that, they were the Senior Director of Finance at QuinStreet from 2004 to 2008. Mary Beth also held positions as the Director of Finance at McDougall Creative from 2001 to 2004, Controller at MusicBank from 2000 to 2001, and Assistant Controller at Law.com from 1998 to 2000. Mary Beth began their career as a Senior Auditor at RR Donnelley from 1996 to 1998 and as a Systems and Financial Auditor at PricewaterhouseCoopers from 1994 to 1996.

Mary Beth Kreissler has a Master of Business Administration (M.B.A.) degree from Columbia Business School and a Bachelor of Science (BS) degree in Accounting from the University of Illinois Urbana-Champaign. No specific start or end years are provided for either of the degrees.